White label ELPA - ClinicalTrials.eu

Study on How Concizumab Works for Patients with Hemophilia A or B with Inhibitors

Not recruiting

3 1 1
Investigated diseases:
- Haemophilia B with anti factor IX
- Haemophilia A with anti factor VIII
Investigated drugs:
- Concizumab
+2
Study on the Safety and Effectiveness of Rozanolixizumab in Children with Generalized Myasthenia Gravis

Not recruiting

4 1 1 1
Investigated diseases:
- Myasthenia gravis
Investigated drugs:
- Immunoglobulins, Normal Human
- Rozanolixizumab
Study on Methotrexate and Glucocorticoid Combination for Early Rheumatoid Arthritis, with Optional Etanercept for Non-Responders

Not recruiting

3 1 1 1
Investigated drugs:
- Etanercept
- Leflunomide
Study on Pembrolizumab, Etoposide, and Cisplatin or Carboplatin for First-Line Treatment in Patients with Extensive-Stage Small Cell Lung Cancer

Not recruiting

2 1 1 1
Investigated diseases:
- Small cell lung cancer
Investigated drugs:
- Boserolimab
- Mk-4830
Study on Nipocalimab for Adults with Active Inflammatory Muscle Diseases

Not recruiting

2 1

+1
Study on Efgartigimod Alfa and Prednisone for Adults with Bullous Pemphigoid

Not recruiting

4 1 1
Investigated drugs:
- Efgartigimod Alfa
- Prednisone
+8
Study on the Effects of Ozanimod for Children with Moderate to Severe Crohn’s Disease Not Responding to Usual Treatments

Not recruiting

4 1 1 1
Investigated diseases:
- Crohn’s disease
Investigated drugs:
- Ozanimod
Study on Binimetinib, Encorafenib, and Pembrolizumab for Patients with BRAF V600 Mutation-Positive Melanoma and Brain Metastasis

Not recruiting

2 1 1 1
Investigated diseases:
- Metastatic malignant melanoma
Investigated drugs:
- Binimetinib
- Encorafenib
Study on the Effectiveness and Safety of Tisagenlecleucel for Adults with Hard-to-Treat or Returning Follicular Lymphoma

Not recruiting

2 1 1 1
Investigated drugs:
- Tisagenlecleucel
+1
Study of Pembrolizumab and Chemotherapy for Patients with Recurrent Platinum-Sensitive Low-Grade Serous Ovarian Cancer

Not recruiting

2 1 1 1
Investigated diseases:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies